A5454812
Moclobemide (Ro 111163) , 98% , 71320-77-9
Synonym(s):
4-Chloro-N-[2-(4-morpholinyl)ethyl]benzamide;Aurorix;Moclamine
CAS NO.:71320-77-9
Empirical Formula: C13H17ClN2O2
Molecular Weight: 268.74
MDL number: MFCD00865388
EINECS: 629-727-7
Pack Size | Price | Stock | Quantity |
10MG | RMB228.80 | In Stock |
|
50MG | RMB905.60 | In Stock |
|
100mg | RMB1574.40 | In Stock |
|
250MG | RMB3039.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 137°C |
Boiling point: | 447.7±40.0 °C(Predicted) |
Density | 1.206±0.06 g/cm3(Predicted) |
storage temp. | room temp |
solubility | DMSO: >20mg/mL |
pka | 14.26±0.46(Predicted) |
form | solid |
color | white |
Merck | 14,6226 |
CAS DataBase Reference | 71320-77-9(CAS DataBase Reference) |
NIST Chemistry Reference | Moclobemide(71320-77-9) |
Description and Uses
Moclobemide is the first of a new generation of non-hydrazine, reversible MAO-A inhibitors useful in the treatment of depression. Moclobemide is a selective inhibitor of MAO-A, allowing tyramine to be metabolized by MAO-B. In controlled studies, moclobemide was clinically superior to desipramine and showed no cholinergic or cardiovascular side-effects. A metabolite is currently under investigation for treatment of Parkinson’s disease,.
A reversible monoamine oxidase inhibitor.
Safety
Symbol(GHS) | GHS05,GHS07 |
Signal word | Danger |
Hazard statements | H302-H315-H318-H335 |
Precautionary statements | P280-P301+P312+P330-P302+P352-P305+P351+P338+P310 |
Hazard Codes | Xn,T+ |
Risk Statements | 22-37/38-41-26/27/28 |
Safety Statements | 26-39-45-36/37/39-22 |
RIDADR | 3249 |
WGK Germany | 2 |
RTECS | CV2462000 |
HazardClass | 6.1(b) |
PackingGroup | III |
HS Code | 29349990 |
Hazardous Substances Data | 71320-77-9(Hazardous Substances Data) |
Toxicity | LD50 in rats (mg/kg): 707 orally (Burkard, Wyss) |